LIGAND PHARMACEUTICALS INCORPORATED Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-08-07
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2026-06-30 was 0.00%.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2026-03-31 was 0.00%.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-09-30 was 0.00%.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-06-30 was 0.00%.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2014 was 0.00%.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2013 was 0.00%.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2012 was 0.00%.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2011 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00% 10-Q · filed 2026-08-07 | 0.00% 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | 0.00% 10-Q · filed 2026-05-08 | |||
| 2025-09-30 | 0.00% 10-Q · filed 2025-11-07 | 0.00% 10-Q · filed 2025-11-07 | ||
| 2025-06-30 | 0.00% 10-Q · filed 2026-08-07 | 0.00% 10-Q · filed 2026-08-07 | ||
| 2025-03-31 | 0.00% 10-Q · filed 2026-05-08 | |||
| 2024-09-30 | 0.00% 10-Q · filed 2025-11-07 | 0.00% 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | 0.00% 10-Q · filed 2025-08-08 | 0.00% 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | 0.00% 10-Q · filed 2025-05-09 | |||
| 2023-09-30 | 0.00% 10-Q · filed 2024-11-08 | 0.00% 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | 0.00% 10-Q · filed 2024-08-07 | 0.00% 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | 0.00% 10-Q · filed 2024-05-08 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2023-11-09 | 0.00% 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | 0.00% 10-Q · filed 2023-08-09 | 0.00% 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | 0.00% 10-Q · filed 2023-05-08 | |||
| 2021-09-30 | 0.00% 10-Q · filed 2022-11-08 | 0.00% 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | 0.00% 10-Q · filed 2022-08-09 | 0.00% 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | 0.00% 10-Q · filed 2022-05-09 | |||
| 2020-09-30 | 0.00% 10-Q · filed 2021-11-09 | 0.00% 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | 0.00% 10-Q · filed 2021-08-03 | 0.00% 10-Q · filed 2021-08-03 | ||
| 2020-03-31 | 0.00% 10-Q · filed 2021-05-06 | |||
| 2019-09-30 | 0.00% 10-Q · filed 2020-11-06 | 0.00% 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | 0.00% 10-Q · filed 2020-08-07 | 0.00% 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | 0.00% 10-Q · filed 2020-05-08 | |||
| 2018-09-30 | 0.00% 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | 0.00% 10-Q · filed 2019-08-08 | 0.00% 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | 0.00% 10-Q · filed 2019-05-09 | |||
| 2017-09-30 | 0.00% 10-Q · filed 2017-11-09 | 0.00% 10-Q · filed 2017-11-09 | ||
| 2017-06-30 | 0.00% 10-Q · filed 2018-08-08 | 0.00% 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | 0.00% 10-Q · filed 2018-05-09 | |||
| 2016-09-30 | 0.00% 10-Q · filed 2017-11-09 | 0.00% 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | 0.00% 10-Q · filed 2017-08-09 | 0.00% 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | 0.00% 10-Q · filed 2017-05-09 | |||
| 2015-09-30 | 0.00% 10-Q · filed 2016-11-14 | 0.00% 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | 0.00% 10-Q · filed 2016-11-14 | 0.00% 10-Q · filed 2016-11-14 | ||
| 2015-03-31 | 0.00% 10-Q · filed 2016-11-14 | |||
| 2014-12-31 | 0.00% 10-K · filed 2015-02-23 | |||
| 2014-09-30 | 0.00% 10-Q · filed 2015-11-09 | 0.00% 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | 0.00% 10-Q · filed 2015-08-05 | 0.00% 10-Q · filed 2015-08-05 | ||
| 2014-03-31 | 0.00% 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | 0.00% 10-K · filed 2015-02-23 | |||
| 2013-09-30 | 0.00% 10-Q · filed 2014-10-31 | 0.00% 10-Q · filed 2014-10-31 | ||
| 2013-06-30 | 0.00% 10-Q · filed 2014-08-05 | |||
| 2013-03-31 | 0.00% 10-Q · filed 2014-05-07 | |||
| 2012-12-31 | 0.00% 10-K · filed 2015-02-23 | |||
| 2011-12-31 | 0.00% 10-K/A · filed 2014-12-12 | |||
| 2010-12-31 | 0.00% 10-K · filed 2013-03-14 |